What is Biological E?
Biological E. Ltd. (BE) is a prominent vaccine and pharmaceutical manufacturer established in 1953 and headquartered in Telangana, India. The company plays a crucial role in India's National Immunization Program, producing a wide array of essential vaccines. Its long-standing presence and contributions highlight its importance in public health initiatives.
How much funding has Biological E raised?
Biological E has raised a total of $5M across 1 funding round:
Grant
$5M
Grant (2020): $5M with participation from Coalition for Epidemic Preparedness Innovations
Key Investors in Biological E
Coalition for Epidemic Preparedness Innovations
The Coalition for Epidemic Preparedness Innovations (CEPI) is a global partnership focused on funding and coordinating the development of vaccines against emerging infectious diseases. Their investment in Biological E. Ltd. likely supports the advancement of critical vaccine research and production capabilities.
What's next for Biological E?
The recent major strategic investment signals a period of accelerated growth and potential expansion for Biological E. This significant capital infusion is likely to bolster its research and development capabilities, enhance manufacturing capacity, and potentially support new market entries or strategic partnerships. The company's established track record in vaccine production positions it favorably to leverage this financing for further innovation and impact in global health.
See full Biological E company page
